investigated whether combining a vitamin D analog (paricalcitol) and an angiotensin receptor blocker (losartan) leads to more effective inhibition of the renin–angiotensin system and prevention ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback